No Data
No Data
Chinese Securities Watchdog to Probe Wuzhong Pharmaceutical Development's Chairman on Suspected Disclosure Violations
On May 15, the A-share investment warning indicator | Special Treat Suwu: The company's Director has received a notice of case filing.
The actual controller of Zhejiang Huace Film & TV, Fu Meicheng, plans to reduce his Shareholding by no more than 20.7612 million shares; State Investment Venture Shanghai Fund, a Shareholder of Changguang Huaxin, plans to reduce its Shareholding by no more than 2%; Shareholders Zhou Xinhua and his concerted parties of Huakai Yibai Technology plan to reduce their Shareholding by a total of no more than 3%; Shareholder Sanan Group of Fujian Yuanli Active Carbon plans to reduce its Shareholding by no more than 3%; the Chairman of Special Treat Suwu has received a notice of filing; Zhuzhou Kibing Group has terminated its plan to issue shares to purchase Assets.
Express News | *Special Treat Suwu: Due to suspected violations of information disclosure regulations, the company's Chairman, Qian Qunshan, has been put under investigation.
Express News | *Special Treat Suwu: The controlling Shareholder pledged 9.57 million shares.
JiangSu WuZhong Pharmaceutical Development (600200.SH) controlling Shareholder related party fund occupation and overlay of Other risk warning.
JiangSu WuZhong Pharmaceutical Development (600200.SH) announced that Zhongxing Caiguanghua Accounting Firm (Special General Partnership) has conducted an audit for the company...
Jiangsu Wuzhong: Full text of the 2024 Annual Report of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.